| Nome |
# |
|
Disease-modifying therapies and coronavirus disease 2019 severity in multiple sclerosis, file e383532c-b6e6-15e8-e053-a505fe0a3de9
|
428
|
|
Cerebellar pathology and disability worsening in relapsing-remitting multiple sclerosis: A retrospective analysis from the CombiRx trial, file e383532d-f9fe-15e8-e053-a505fe0a3de9
|
206
|
|
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study, file e383532f-17dd-15e8-e053-a505fe0a3de9
|
169
|
|
Classification of multiple sclerosis patients based on structural disconnection: A robust feature selection approach, file e383532e-9e2f-15e8-e053-a505fe0a3de9
|
102
|
|
A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis., file e383532c-11aa-15e8-e053-a505fe0a3de9
|
93
|
|
Retinal and choriocapillary vascular changes in early stages of multiple sclerosis: A prospective study, file e383532d-a8c1-15e8-e053-a505fe0a3de9
|
88
|
|
Validation of the Italian version of the Multiple Sclerosis Intimacy and Sexuality Questionnaire-19, file e3835329-3b78-15e8-e053-a505fe0a3de9
|
84
|
|
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study, file fae2fd31-7593-4a48-a023-d8793f09c062
|
77
|
|
Quantitative MRI in Multiple Sclerosis: From Theory to Application, file ff707dbd-65a8-447f-b1dd-8c82b215e4d3
|
67
|
|
Machine learning classifier to identify clinical and radiological features relevant to disability progression in multiple sclerosis, file e383532c-6caf-15e8-e053-a505fe0a3de9
|
66
|
|
Physical Exercise Moderates the Effects of Disability on Depression in People with Multiple Sclerosis during the COVID-19 Outbreak, file e383532c-e4ba-15e8-e053-a505fe0a3de9
|
57
|
|
Disability outcomes in early-stage African American and White people with multiple sclerosis, file a71590ed-9c1b-454a-8243-b96af6d8eeb9
|
56
|
|
Cognitive trajectories in multiple sclerosis: a long-term follow-up study, file e383532c-fe28-15e8-e053-a505fe0a3de9
|
55
|
|
Structural disconnection and functional reorganization in Fabry disease: a multimodal MRI study, file 18be914e-f779-46f2-84eb-19d8ec3b343a
|
52
|
|
Laminar analysis of the cortical T1/T2-weighted ratio at 7T, file e383532c-2de5-15e8-e053-a505fe0a3de9
|
51
|
|
Sensory-motor network topology in multiple sclerosis: Structural connectivity analysis accounting for intrinsic density discrepancy., file e383532b-ea6a-15e8-e053-a505fe0a3de9
|
50
|
|
A composite measure to explore visual disability in primary progressive multiple sclerosis, file e383532b-ef58-15e8-e053-a505fe0a3de9
|
50
|
|
Disease-modifying therapies and coronavirus disease 2019 severity in multiple sclerosis, file e3835329-a2b2-15e8-e053-a505fe0a3de9
|
49
|
|
Neuroimaging correlates of cognitive dysfunction in adults with multiple sclerosis, file e383532c-6b51-15e8-e053-a505fe0a3de9
|
49
|
|
Body Mass Index in Multiple Sclerosis modulates ceramide-induced DNA methylation and disease course., file e383532c-418f-15e8-e053-a505fe0a3de9
|
47
|
|
Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS, file e383532b-eda2-15e8-e053-a505fe0a3de9
|
46
|
|
Cerebellar volume as imaging outcome in progressive multiple sclerosis, file e383532b-d341-15e8-e053-a505fe0a3de9
|
45
|
|
Peripapillary Vessel Density as Early Biomarker in Multiple Sclerosis, file e383532b-f092-15e8-e053-a505fe0a3de9
|
45
|
|
Monitoring Progressive Multiple Sclerosis with Novel Imaging Techniques., file e383532b-f925-15e8-e053-a505fe0a3de9
|
45
|
|
Gender Inequities in the Multiple Sclerosis Community: A Call for Action., file e383532c-2252-15e8-e053-a505fe0a3de9
|
44
|
|
Sporadic Porphyria Cutanea Tarda in a Patient with Multiple Sclerosis Treated with Interferon Beta 1-a Therapy: A Case Report, file e383532c-2703-15e8-e053-a505fe0a3de9
|
44
|
|
The relationship between cortical lesions and periventricular NAWM abnormalities suggests a shared mechanism of injury in primary-progressive MS., file e383532b-e5c5-15e8-e053-a505fe0a3de9
|
43
|
|
Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg, file e383532b-cfbd-15e8-e053-a505fe0a3de9
|
42
|
|
Synchronization and variability imbalance underlie cognitive impairment in primary-progressive multiple sclerosis., file e383532b-f04a-15e8-e053-a505fe0a3de9
|
42
|
|
Retrospective unbiased plasma lipidomic of progressive multiple sclerosis patients-identifies lipids discriminating those with faster clinical deterioration., file e383532c-a55b-15e8-e053-a505fe0a3de9
|
42
|
|
Cerebellum and neurodegenerative diseases: Beyond conventional magnetic resonance imaging, file e383532b-d0c2-15e8-e053-a505fe0a3de9
|
41
|
|
Tractography dissection variability: What happens when 42 groups dissect 14 white matter bundles on the same dataset?, file e383532c-e32a-15e8-e053-a505fe0a3de9
|
41
|
|
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study, file e383532c-6b53-15e8-e053-a505fe0a3de9
|
40
|
|
Interplay Between Cognitive and Bowel/Bladder Function in Multiple Sclerosis, file e383532c-bd28-15e8-e053-a505fe0a3de9
|
40
|
|
Tract-specific white matter correlates of fatigue and cognitive impairment in benign multiple sclerosis, file e383532b-f779-15e8-e053-a505fe0a3de9
|
39
|
|
Possible progressive multifocal leukoencephalopathy and active multiple sclerosis under dimethyl fumarate: the central role of MRI in informing therapeutic decisions, file e383532c-6b4f-15e8-e053-a505fe0a3de9
|
39
|
|
Walk your talk: Real-world adherence to guidelines on the use of MRI in multiple sclerosis, file e383532c-cdfa-15e8-e053-a505fe0a3de9
|
39
|
|
A retrospective exploratory analysis on cardiovascular risk and cognitive dysfunction in multiple sclerosis, file e383532c-653f-15e8-e053-a505fe0a3de9
|
38
|
|
Mental Health in Multiple Sclerosis During the COVID-19 Outbreak: A Delicate Balance between Fear of Contagion and Resilience, file e383532e-0a90-15e8-e053-a505fe0a3de9
|
38
|
|
AQP4-MOG Double-Positive Neuromyelitis Optica Spectrum Disorder: Case Report with Central and Peripheral Nervous System Involvement and Review of Literature, file 0151b78a-8909-4bae-b0a0-ab122cc55c4e
|
37
|
|
A matter of atrophy: differential impact of brain and spine damage on disability worsening in multiple sclerosis, file e383532c-3f16-15e8-e053-a505fe0a3de9
|
34
|
|
Risk of Getting COVID-19 in People with Multiple Sclerosis A Case-Control Study, file e383532e-faaf-15e8-e053-a505fe0a3de9
|
33
|
|
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study, file e383532e-6c92-15e8-e053-a505fe0a3de9
|
32
|
|
Stratification of multiple sclerosis patients using unsupervised machine learning: a single-visit MRI-driven approach, file e383532e-b6bc-15e8-e053-a505fe0a3de9
|
20
|
|
Evaluation of Disability Progression in Multiple Sclerosis via Magnetic-Resonance-Based Deep Learning Techniques, file 08717e37-e258-4565-aca5-2afbfe7b73f9
|
18
|
|
Editorial: Multi-Modal Imaging in Neurological Conditions: Translational Applications, file e383532e-9795-15e8-e053-a505fe0a3de9
|
18
|
|
Association of deep gray matter damage with cortical and spinal cord degeneration in primary progressive multiple sclerosis, file e3835329-3810-15e8-e053-a505fe0a3de9
|
16
|
|
Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple Sclerosis, file 2203abab-8cde-42a3-8a4c-28294ffb7870
|
14
|
|
Correlation analysis between foveal avascular zone and near peripheral retinal hypoperfusion in multiple sclerosis: a wide field optical coherence tomography angiography study, file c979afc5-5810-4b75-b8ce-6fd10955741e
|
14
|
|
Eating Hubs in Multiple Sclerosis: Exploring the Relationship Between Mediterranean Diet and Disability Status in Italy, file 56a10a63-c5c4-445e-8c68-57b429a67da3
|
12
|
|
Persistence, adherence, healthcare resource utilization and costs for ocrelizumab in the real-world of the Campania Region of Italy, file c346c067-72d2-40b5-b284-19ef2c985476
|
10
|
|
Ocrelizumab effect on humoral and cellular immunity in multiple sclerosis and its clinical correlates: a 3-year observational study, file 7dc57a08-3368-4330-85c6-b62cfd9218ba
|
8
|
|
Quality of Life Changes in Early-Onset Multiple Sclerosis: A 4-Year Follow-Up Study, file 6b2c701f-eb2e-4265-9983-14830a85c8a2
|
7
|
|
Low serum 25‑hydroxy-vitamin D levels are associated with cognitive impairment in multiple sclerosis, file 60209928-3eee-40f1-b8fd-172f9ed8cbfd
|
6
|
|
Clinical correlates of R1 relaxometry and magnetic susceptibility changes in multiple sclerosis: a multi-parameter quantitative MRI study of brain iron and myelin, file 4d8ee384-bcb3-4f89-9e92-6f2ff5ed5e41
|
5
|
|
Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and Depression, file c8a27f75-1e97-4387-8cdf-06ab9e5df5be
|
4
|
|
Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors, file 25207592-b486-490b-b3af-e3e11b7cd495
|
3
|
|
The added value of spinal cord lesions to disability accrual in multiple sclerosis, file 58a49d70-c828-4d5e-bd1d-89f40ed29ecc
|
3
|
|
Changes in lymphocytes, neutrophils and immunoglobulins in year-1 cladribine treatment in multiple sclerosis, file e383532d-a860-15e8-e053-a505fe0a3de9
|
3
|
|
Exploring the relation between reserve and fatigue in multiple sclerosis, file f570d367-de21-4e02-9d82-e1e5cbef29d1
|
3
|
|
Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience, file 731418f5-88d9-4599-b7db-95cd176c8ecd
|
2
|
|
Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate, file e383532b-f848-15e8-e053-a505fe0a3de9
|
2
|
|
Efficacy of levetiracetam in hemifacial spasm: a case report, file e383532c-0ac4-15e8-e053-a505fe0a3de9
|
2
|
|
Cognitive performance in mid-stage Parkinson's disease: functional connectivity under chronic antiparkinson treatment, file e383532c-0c1f-15e8-e053-a505fe0a3de9
|
2
|
|
Relationship Between Retinal Layer Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple Sclerosis, file e383532c-b716-15e8-e053-a505fe0a3de9
|
2
|
|
ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trial, file e383532c-c63f-15e8-e053-a505fe0a3de9
|
2
|
|
Google Maps Timeline: An open-access digital tool to monitor walking abilities in people with multiple sclerosis, file f5c6378e-fd3a-4e7c-b47c-859a5da838df
|
2
|
|
MR Imaging Signs of Gadolinium Retention Are Not Associated with Long-Term Motor and Cognitive Outcomes in Multiple Sclerosis, file 0a40fb0b-1907-448d-967d-c624fba7a578
|
1
|
|
The independent contribution of brain, spinal cord and gadolinium MRI in treatment decision in multiple sclerosis: A population-based retrospective study, file 514322d1-aca7-41ad-9925-d1d868a91775
|
1
|
|
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis, file 5a68c302-d5c8-4d10-be8e-78348d222066
|
1
|
|
The impact of image contrast, resolution and reader expertise on black hole identification in Multiple Sclerosis, file 824e207c-9128-45df-a296-b66a05e2c265
|
1
|
|
Switching to ozanimod as a strategy to adjust fingolimod-related lymphopenia, file ce5b1ebb-ed96-4b37-9bd1-1ed55ea4f66b
|
1
|
|
Fertility, pregnancy and childbirth in women with multiple sclerosis: a population-based study from 2018 to 2020, file da51efcf-fe87-41f3-874d-94be628b1879
|
1
|
|
The Development of Subcortical Gray Matter Atrophy in Multiple Sclerosis: One Size Does Not Fit All, file e383532b-cd27-15e8-e053-a505fe0a3de9
|
1
|
|
Idiopathic late-onset cerebellar ataxia with cerebellar atrophy in a patient diagnosed with Chiari I malformation: a case report, file e383532b-cdbc-15e8-e053-a505fe0a3de9
|
1
|
|
Lower cortical gamma-aminobutyric acid level contributes to connectivity in sensory-motor inter-connected regions in progressive MS, file e383532b-ce6b-15e8-e053-a505fe0a3de9
|
1
|
|
Tolosa-Hunt syndrome in a patient with autoimmune hemolytic anemia, file e383532b-cfa5-15e8-e053-a505fe0a3de9
|
1
|
|
A metabolic perspective on CSF-mediated neurodegeneration in multiple sclerosis, file e383532b-d0c3-15e8-e053-a505fe0a3de9
|
1
|
|
Sodium MRI of multiple sclerosis., file e383532b-e322-15e8-e053-a505fe0a3de9
|
1
|
|
Cerebellum and cognition in progressive MS patients: functional changes beyond atrophy?, file e383532b-e955-15e8-e053-a505fe0a3de9
|
1
|
|
SUITer: an automated method for improving segmentation of infratentorial structures at ultra-high field MRI, file e383532b-ea42-15e8-e053-a505fe0a3de9
|
1
|
|
Diffusion Kurtosis Mapping., file e383532b-ebf9-15e8-e053-a505fe0a3de9
|
1
|
|
Psychiatric onset of multiple sclerosis: description of two cases, file e383532b-ebfa-15e8-e053-a505fe0a3de9
|
1
|
|
Imaging multiple sclerosis and other neurodegenerative diseases, file e383532b-ebfc-15e8-e053-a505fe0a3de9
|
1
|
|
MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis, file e383532b-fb45-15e8-e053-a505fe0a3de9
|
1
|
|
Upper motor neuron evaluation in multiple sclerosis patients treated with Sativex(®), file e383532b-fb46-15e8-e053-a505fe0a3de9
|
1
|
|
Glossopharyngeal neuralgia as onset of multiple sclerosis, file e383532b-fb47-15e8-e053-a505fe0a3de9
|
1
|
|
Non-invasive quantification of inflammation, axonal and myelin injury in multiple sclerosis, file e383532c-0486-15e8-e053-a505fe0a3de9
|
1
|
|
Looking into cognitive impairment in primary-progressive multiple sclerosis., file e383532c-0c21-15e8-e053-a505fe0a3de9
|
1
|
|
Depression is associated with disconnection of neurotransmitter-related nuclei in multiple sclerosis, file e383532c-0f87-15e8-e053-a505fe0a3de9
|
1
|
|
2D linear measures of ventricular enlargement may be relevant markers of brain atrophy and long-term disability progression in multiple sclerosis, file e383532c-1002-15e8-e053-a505fe0a3de9
|
1
|
|
Brain microstructural injury occurs in patients with RRMS despite 'no evidence of disease activity', file e383532c-187c-15e8-e053-a505fe0a3de9
|
1
|
|
Clinical applications of ultra-high field magnetic resonance imaging in multiple sclerosis., file e383532c-187f-15e8-e053-a505fe0a3de9
|
1
|
|
Neuroimaging of multiple sclerosis, acute disseminated encephalomyelitis, and other demyelinating diseases, file e383532c-1c59-15e8-e053-a505fe0a3de9
|
1
|
|
An MRI evaluation of grey matter damage in African Americans with MS., file e383532c-1d71-15e8-e053-a505fe0a3de9
|
1
|
|
Brain intra- and extracellular sodium concentration in multiple sclerosis: a 7 T MRI study., file e383532c-1f52-15e8-e053-a505fe0a3de9
|
1
|
|
Therapeutic strategies in multiple sclerosis: A focus on neuroprotection and repair and relevance to schizophrenia, file e383532c-2329-15e8-e053-a505fe0a3de9
|
1
|
|
MRI in multiple sclerosis: clinical and research update, file e383532c-2468-15e8-e053-a505fe0a3de9
|
1
|
|
Mild or no COVID-19 symptoms in cladribine-treated multiple sclerosis: Two cases and implications for clinical practice, file e383532c-24cd-15e8-e053-a505fe0a3de9
|
1
|
|
Streamline density and lesion volume reveal a postero-anterior gradient of corpus callosum damage in multiple sclerosis, file e383532c-26fd-15e8-e053-a505fe0a3de9
|
1
|
| Totale |
3.036 |